Through rapid prototyping and creative experimentation, Harald and his students explore how emerging technologies can reshape the way we interact with both digital and physical environments.
Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against subsequent exposure to a different flu strain.
Cornell researchers are recommending new guidelines for developing safe and responsible large language model-based mental well-being apps by consulting relevant experts and reviewing existing state and federal regulations.
EdemaFlex, a new glove with more than three dozen actuators across all five fingers and the palm, developed by Cornell researchers, aims to reduce swelling for people suffering from edema.
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones that evade the immune system, making the disease difficult to cure.
An additional $6 million in funding over the next four years will bolster the Support for Promising Research Opportunities and Unconventional Teams program, designed to encourage emerging collaborations at the intersection of research fields.
Jens David Ohlin has been appointed to a second term as the Allan R. Tessler Dean of Cornell Law School, effective July 1. The Cornell Board of Trustees Executive Committee voted March 9 to approve the new term.
Fred Rubinstein ’52, LLB ’55, has honored his late wife’s dedication to civic engagement by endowing a professorship in the Department of Government in the College of Arts and Sciences.
The popular diabetes and weight-loss medication tirzepatide may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.